Browse studies

Find your next paid study

26,882 recruiting studies available now

Project ARTEMIS: A Mechanistic Clinical Trial of Neuroimmune Pathways.

The purpose of this research is to understand how chronic stress affects the way our brain and immune systems function, and in turn how this affects the way pe…

Stimulant UseHuman Immunodeficiency Virus (HIV)Depression

Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT06814275

Phase 2

A Two-part, Seamless, Multicenter, Randomized, Open-label, Adaptive Phase II/III Study of the Blood-brain Barrier Penetrant RO7771950 Versus Tucatinib, Both in Combination With Trastuzumab and Capecitabine, in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2-Positive Breast Cancer, With or Without Central Nervous System Metastases

The purpose of this study is to assess the efficacy and safety of RO7771950 in combination with trastuzumab and capecitabine, compared to tucatinib in combinat…

HER2-positive Breast Cancer

Estimated

~$10 – $7,500

Hoffmann-La RocheNCT07413939

Observational

Community-viable Family-school Partnership Intervention for Children With Social-communication Deficits in Early Childhood Education

Strategies for creating and maintaining reciprocal partnerships between teachers and parents are considered essential elements of developmentally appropriate p…

Autism Spectrum Disorder

Estimated

~$10 – $6,250

University of North Texas, Denton, TXNCT06506097

Phase 1

A Phase 1a/1b Dose Escalation, Dose Expansion Study of SW-682 in Participants With Advanced Solid Tumors Enriched for Those With Hippo Pathway Mutations

This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic o…

Advanced Solid TumorMesothelioma, Malignant

Estimated

~$10 – $8,750

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyNCT06251310

Screening Emotions in Adolescents Receiving Care at the Hospital for mTBI (SEARCH-mTBI)

The goal of this observational study is to develop and validate a clinical tool to predict which adolescents aged 11 to less than 18 years of age with mild tra…

Brain Injury Traumatic MildBrain InjuriesBrain Injuries, Acute+7 more

Estimated

~$10 – $750

University of California, DavisNCT06370520

Phase 2

A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Metastatic Colorectal Cancer

CRC is the third most common type of cancer diagnosed worldwide with developed countries at highest risk. The purpose of this study is to assess adverse events…

Metastatic Colorectal Cancer

A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults With Relapsed or Refractory Disease

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage ac…

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia

Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT03739814

Observational

Encouraging Flu Vaccination Among High-Risk Patients Identified by a Rule-Based Additive Risk Index

Previous work by the study team has shown that informing patients of their high risk of flu and flu-related complications increases their likelihood of getting…

InfluenzaVaccinationRisk Reduction+2 more

Estimated

~$10 – $6,250

Geisinger ClinicNCT07798882

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovas…

Elevated Lp(a)Atherosclerotic Cardiovascular Disease (ASCVD)

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07157774

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Stu…

Alzheimer's Disease

Estimated

~$10 – $750

University of PennsylvaniaNCT05658913

Phase 3

A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia

The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromya…

Fibromyalgia

Estimated

~$10 – $8,750

Axsome Therapeutics, Inc.NCT07398417

Observational

TweenVax: A Comprehensive Practice-, Provider-, and Parent/Patient-Level Intervention to Improve Adolescent HPV Vaccination

This clinical trial compares the effect of a vaccine promotional intervention, TweenVax, to standard of care vaccination promotion practices on rates of human …

Human Papillomavirus-Related Carcinoma

Estimated

~$10 – $6,250

Emory UniversityNCT07104240